Advancing The Future of Proton Therapy
APRIL 14 – 16, 2021
ONLINE
Advancing The Future of Proton Therapy
APRIL 14 – 16, 2021 | ONLINE
NAPT 2021 IS LIVE!
Check the Agenda for programming starting at 8:55 AM EST
On April 15 and 16, 2021, NAPT will bring together the proton therapy community in a virtual format that builds on the success of our 2020 virtual education foundation with the addition of new opportunities and features.
This year we continue our mission to educate and increase awareness about the clinical benefits of proton therapy, ensure patient’s choice and access, and to encourage cooperative research and innovation. We are committed to move the proton industry forward and look forward to the opportunity to engage with all of you. Our community has united through the opportunities these challenging times have presented and our continued goal is to connect the brightest minds and visionaries in the field to advance the future of proton therapy – a future shaped by our collaboration to initiate, illuminate, and innovate together.
Program Tracks
Clinical Topics in Proton Therapy
Hot Clinical Topics on Proton Therapy
Proton Therapy Clinical Research: The Path Forged, Lessons Learned, and Future Directions
Proton Center Operations
Improving Operational Efficiency in a Proton Center
Proton Radiation Oncology Coding/Reimbursement and Insurance Coverage
Equity, Diversity and Inclusion (EDI)
Appeal Letter Writing 101: Laying the Groundwork for a Successful Prior Authorization
Patient and Care Partner Storytelling: Getting Key Messages Across in the Virtual World
Update from National Comprehensive Cancer Network
Improving Patient Access to Proton Therapy Through Value-Based Initiatives
Innovative Solutions to Advance the Proton Therapy Insurance Appeal Process
Innovative Approaches for Developing a Strong Physician Referral Network
Radiation Oncology Alternative Payment Model – 3 Things to Do Now
New and Developing Centers
Considerations in Design and Construction for Proton Therapy Development
Evolution of Single Room Proton Therapy Development
Financing Options for Developing Proton Centers and Expansion Projects
Key Considerations When Developing a Proton Therapy Center
What Past Participants Say
“Thank you for an exceptional virtual conference. So well done all around! It was wonderful to engage with the proton community and “see” colleagues and learn so much. Wonderful job all around.”
Fern Nibauer-Cohen
Director of Patient Engagement and Business, Radiation Oncology Department, Penn Medicine
“I too congratulate all who worked tirelessly to organize. Best virtual conference yet!”
Dayna Bodensteiner
Director of Product Management RaySearch Americas
“I also want to express my sincere thank you to Jennifer, the NAPT, and the conference committee for a great virtual conference with a great high-quality program. Well done by everybody.”
Dayna Bodensteiner
Director of Product Management RaySearch Americas
NAPT National Proton Conference Committee
Kristin Morris Heath | Program Chair
Abram Gordon | Cincinnati Children’s / UC Health Proton Therapy Center
Arpit Chhabra, MD | New York Proton Center
Brad Robbert | University of Florida Health Proton Therapy Institute
Brian Baumann, MD | S. Lee Kling Proton Therapy Center at the Siteman Cancer Center
David Raubach | Oklahoma Proton Center
Jason Caron | McDermott Will & Emery
Joy Godby | MD Anderson Cancer Center Proton Therapy Center Houston
Kimberly Simmons-Lee | Maryland Proton Treatment Center
Kristin Morris Heath | Miami Cancer Institute at Baptist Health South Florida
Leonard Arzt | Stantec Particle Therapy Consultant
Matt Ladra, MD | Johns Hopkins National Proton Therapy Center
Nancy Howard | Provision CARES Proton Therapy
Fern Nibauer-Cohen | UPenn Roberts Proton Therapy Center
Peng Wang, PhD | Inova Schar Cancer Institute
Rob Bahnsen | SCCA Proton Therapy Center
Rob Tokarz | Ackerman Cancer Center
Vickie Miller | Mayo Clinic Scottsdale
Yoly Magana | Loma Linda University Medical Center
Our Partners
PRESENTING SPONSOR
EXECUTIVE SPONSORS
LEADER SPONSORS
SPONSORS
EXHIBITORS
